Abstract
Cannabis sativa is an ancient medicinal crop that has seen a recent resurgence in therapeutic applications. Its medicinal value is largely attributed to two chemical compound classes, cannabinoids and terpenes. Cannabinoids are unique to Cannabis and major cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), provide benefit through direct interactions with the human endocannabinoid system. Terpenes are important to improve sensory aspects of Cannabis products, while some have further been shown to modulate the efficacy of cannabinoids. While the biochemical pathways of cannabinoid and terpene production are well characterised, knowledge on the natural variation and genetic control underpinning the respective chemotype diversity of Cannabis is only beginning to emerge. Here we report on quantitative trait loci (QTL) mapping for major cannabinoids and terpenes in a segregating biparental mapping population derived from a CBD-dominant and a THC-dominant landrace of contrasting monoterpene compositions. An F2 population of 155 female plants was clonally propagated and phenotyped for chemical composition of mature floral tissues in two contrasting protected cropping environments. We found that four major cannabinoids were controlled by a single locus on Chromosome 7, while six of the most abundant monoterpenes were controlled by a single locus on Chromosome 5. Expression analysis on secondary metabolite-producing glandular trichomes from both parental lines pinpointed several cannabinoid synthases and terpene synthases in proximity to the respective QTL peak markers as putative candidate genes.

This publication has 42 references indexed in Scilit: